Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help...
81 insider purchases on record · latest filing 2026-08-13.
Insiders have also filed 134 sale transactions at BDSX.